These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3069192)

  • 21. Primary prevention of coronary heart disease. A socio-pediatric problem.
    de Haas JH
    Maandschr Kindergeneeskd; 1973 Apr; 41(1):37-52. PubMed ID: 4577898
    [No Abstract]   [Full Text] [Related]  

  • 22. NIH Consensus Development Conference on lowering blood cholesterol to prevent heart disease: implications for dietitians.
    Ernst ND
    J Am Diet Assoc; 1985 May; 85(5):586-8. PubMed ID: 3989174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutrient--high-density lipoprotein relationships: an overview.
    Rifkind BM
    Prog Biochem Pharmacol; 1983; 19():89-109. PubMed ID: 6338526
    [No Abstract]   [Full Text] [Related]  

  • 24. [The medical practitioner facing arteriosclerotic vascular disease].
    Catenazzo G; Torri A; Mantero M
    Minerva Med; 1981 Sep; 72(34):2283-8. PubMed ID: 7290455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.
    Martens LL; Guibert R
    Clin Ther; 1994; 16(6):1052-62; discussion 1036. PubMed ID: 7697684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density lipoprotein cholesterol-raising strategies.
    Kuvin JT; Alsheikh-Ali AA; Karas RH
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):196-204. PubMed ID: 16495756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention in coronary heart disease.
    Stamler J
    Singapore Med J; 1974 Mar; 15(1):4-24. PubMed ID: 4601891
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum lipid and lipoprotein profile in children with malabsorption: an approach to the recognition of atherosclerosis risk factors.
    Szczepański Z; Malecka-Torbus A; Obuchowicz A; Swietochowska I; Zaba R; Wróbel-Lasok B
    Acta Paediatr Acad Sci Hung; 1981; 22(4):309-12. PubMed ID: 6952747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy.
    Denke MA
    Circulation; 2005 Nov; 112(22):3368-70. PubMed ID: 16316961
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory].
    Zöllner N; Keller C
    Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL
    J Am Coll Cardiol; 2008 Apr; 51(15):1512-24. PubMed ID: 18402913
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationships of pediatric nutrients to lipids, lipoproteins, and ultimate risk of atherosclerosis.
    Glueck CJ; Morrison JA
    Pediatr Ann; 1981 Nov; 10(11):45-51. PubMed ID: 7339548
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of lipid disturbances in patients with angiographically confirmed coronary artery disease.
    Válek J; Grafnetter D; Fabián J; Belán A
    Nutr Metab; 1974; 16(4):193-202. PubMed ID: 4837726
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholesterol and atherosclerosis-fact or fiction?
    Nash DT
    Geriatrics; 1981 Jan; 36(1):128-32. PubMed ID: 7450502
    [No Abstract]   [Full Text] [Related]  

  • 38. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dyslipidemia, atherosclerosis and heart disease. Epidemiology and prevention].
    Rabaneda Vallecillos R
    Rev Enferm; 1990 Dec; 13(148):68-73. PubMed ID: 2277915
    [No Abstract]   [Full Text] [Related]  

  • 40. Lowering serum cholesterol levels.
    Stehbens WE
    N Z Med J; 1990 Sep; 103(898):461. PubMed ID: 2216121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.